Golumbeski George insider trades
Golumbeski George has filed 22 Form 4s with the SEC that we hold, for SAGE (Director), Shattuck Labs, Inc. (STTK) (Director), MURA (Director) and Acumen Pharmaceuticals, Inc. (ABOS) (Director). Across all of them we count 4 purchases worth $451.4K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 8,000 shares of SAGE worth $251.6K, dated 2022-05-05. The first filing on our record is dated 2022-01-05 and the latest 2026-06-05.
SAGE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-05 | P, purchase reported on Form 4 | 8,000 | $251.6K | 2022-05-09 |
Shattuck Labs, Inc. (STTK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-21 | P, purchase reported on Form 4 | 26,049 | $96.1K | 2022-04-26 |
| 2022-04-22 | P, purchase reported on Form 4 | 234 | $859 | 2022-04-26 |
| 2022-04-26 | P, purchase reported on Form 4 | 28,330 | $102.8K | 2022-04-27 |
MURA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Acumen Pharmaceuticals, Inc. (ABOS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1586660) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms